```

Exhibit 99.2

          Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to
                       Section 302 of The Sarbanes-Oxley Act of 2002

I, Thomas McAdam, the Chief Executive Officer and Chief Financial Officer of Vibrant Health
International (the "Company"), certify that:

1. I have reviewed this quarterly report on Form 10-QSB of the Company;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

4. As the registrant's certifying officer, I am responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and
15d-14) for the registrant and I have:

      a)    designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this
quarterly report is being prepared;

      b)    evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this quarterly report
(the "Evaluation Date"); and

      c)    presented in this quarterly report my conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. As the registrant's certifying officer, I have disclosed, based on my most recent
evaluation, to the registrant's auditors and the audit committee of registrant's board of
directors (or persons performing the equivalent function):

      a)    all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process, summarize and
report financial data and have identified for the registrant's auditors any material
weaknesses in internal controls; and

      b)    any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrant's internal controls; and

6. I have indicated in this quarterly report whether or not there were significant changes
in internal controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

                                          /s/Thomas McAdam
                                          ------------------------
                                          Thomas McAdam
                                          Chief Executive Officer and
                                          Chief Financial Officer
May 15, 2003
```